Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,379,665,285
-$392,158,178 QoQ
Shares Held
18,518,796
-19.6% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#20
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. MRK ranks #6 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,379,665,285 | 18,518,796 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,771,823,463 | 23,042,842 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,973,981,831 | 18,753,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,141,558,870 | 13,601,321 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $854,768,887 | 10,797,990 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,056,101,079 | 11,765,832 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,244,594,976 | 12,511,007 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,551,928,950 | 22,472,076 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,060,962,551 | 24,725,061 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,910,934,268 | 29,639,517 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,280,108,396 | 30,087,217 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $3,014,187,085 | 29,278,165 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,391,356,986 | 29,390,389 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,174,508,971 | 29,838,415 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,919,541,627 | 26,314,030 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,314,370,759 | 15,262,085 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,552,347,031 | 17,026,950 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,223,814,559 | 14,915,473 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,326,240,101 | 17,304,803 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,389,675,455 | 18,501,870 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,195,589,473 | 15,373,402 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,381,139,172 | 17,915,922 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,550,615,808 | 18,956,192 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,560,846,568 | 18,816,707 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,274,634,114 | 16,483,041 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,100,413,349 | 14,302,233 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||